A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors

Jeffrey Goh, Ben Gao, Ben Markman, Hui Gan, Mark Voskoboynik, Yi-Long Wu, Jun Guo, Qing Zhou, Jun Zhao, Cheng Chen, Jingjun Qiu, Yingying Xu, Liu Yang, Michael Millward

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages2
JournalCancer Research
Volume79
Issue number13
DOIs
Publication statusPublished - Jul 2019
EventAnnual Meeting of the American-Association-for-Cancer-Research (AACR) - Atlanta, Gabon
Duration: 29 Mar 20193 Apr 2019

Cite this

Goh, Jeffrey ; Gao, Ben ; Markman, Ben ; Gan, Hui ; Voskoboynik, Mark ; Wu, Yi-Long ; Guo, Jun ; Zhou, Qing ; Zhao, Jun ; Chen, Cheng ; Qiu, Jingjun ; Xu, Yingying ; Yang, Liu ; Millward, Michael. / A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors. In: Cancer Research. 2019 ; Vol. 79, No. 13.
@article{182e7a6bbf7e474aa1c56dd4a62fc112,
title = "A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors",
author = "Jeffrey Goh and Ben Gao and Ben Markman and Hui Gan and Mark Voskoboynik and Yi-Long Wu and Jun Guo and Qing Zhou and Jun Zhao and Cheng Chen and Jingjun Qiu and Yingying Xu and Liu Yang and Michael Millward",
year = "2019",
month = "7",
doi = "10.1158/1538-7445.AM2019-CT167",
language = "English",
volume = "79",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research (AACR)",
number = "13",

}

A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors. / Goh, Jeffrey; Gao, Ben; Markman, Ben; Gan, Hui; Voskoboynik, Mark; Wu, Yi-Long; Guo, Jun; Zhou, Qing; Zhao, Jun; Chen, Cheng; Qiu, Jingjun; Xu, Yingying; Yang, Liu; Millward, Michael.

In: Cancer Research, Vol. 79, No. 13, 07.2019.

Research output: Contribution to journalAbstract/Meeting Abstract

TY - JOUR

T1 - A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors

AU - Goh, Jeffrey

AU - Gao, Ben

AU - Markman, Ben

AU - Gan, Hui

AU - Voskoboynik, Mark

AU - Wu, Yi-Long

AU - Guo, Jun

AU - Zhou, Qing

AU - Zhao, Jun

AU - Chen, Cheng

AU - Qiu, Jingjun

AU - Xu, Yingying

AU - Yang, Liu

AU - Millward, Michael

PY - 2019/7

Y1 - 2019/7

U2 - 10.1158/1538-7445.AM2019-CT167

DO - 10.1158/1538-7445.AM2019-CT167

M3 - Abstract/Meeting Abstract

VL - 79

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 13

ER -